Fatty liver disease and obesity in youth

被引:9
作者
Della Corte, Claudia
Mazzotta, Anna Rita
Nobili, Valerio
机构
[1] Bambino Gesu Pediat Hosp, IRCCS, Hepatometabol Dept, Rome, Italy
[2] Bambino Gesu Pediat Hosp, IRCCS, Liver Res Unit, Rome, Italy
关键词
children; nonalcoholic fatty liver disease; obesity; treatment; ESPGHAN HEPATOLOGY COMMITTEE; BODY-MASS INDEX; NONALCOHOLIC STEATOHEPATITIS; DOCOSAHEXAENOIC ACID; BARIATRIC SURGERY; POSITION PAPER; CHILDREN; ADOLESCENTS; METAANALYSIS; OVERWEIGHT;
D O I
10.1097/MED.0000000000000221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewThe purpose of this short review is to summarize recent developments in the understanding of pediatric nonalcoholic fatty liver disease (NAFLD), focusing on novel findings in pathogenetic mechanisms and the therapeutic armamentarium.Recent findingsAs a result of the increasing prevalence of pediatric obesity, NAFLD has rapidly become the most common cause of chronic hepatopathies in children. Lifestyle modification and diet remain the mainstay of treatment of pediatric obesity and NAFLD, but with disappointing results because of the difficulty in obtaining sustained long-term results. Considering the risk of progression of liver damage to cirrhosis and end-stage liver disease, in the last decades scientific research in this field has been directed to the identification of pathogenetic mechanisms and possible therapeutic strategies for NAFLD.SummaryWe describe the therapeutic options for the management of pediatric NAFLD, focusing on emerging alternative strategies, including surgical approaches and new drugs directed against novel potential molecular targets.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 35 条
[1]   Liver Transplantation for Nonalcoholic Steatohepatitis The New Epidemic [J].
Agopian, Vatche G. ;
Kaldas, Fady M. ;
Hong, Johnny C. ;
Whittaker, Meredith ;
Holt, Curtis ;
Rana, Abbas ;
Zarrinpar, Ali ;
Petrowsky, Henrik ;
Farmer, Douglas ;
Yersiz, Hasan ;
Xia, Victor ;
Hiatt, Jonathan R. ;
Busuttil, Ronald W. .
ANNALS OF SURGERY, 2012, 256 (04) :624-633
[2]   Recent advances in the development of farnesoid X receptor agonists [J].
Ali, Ahmad H. ;
Carey, Elizabeth J. ;
Lindor, Keith D. .
ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (01)
[3]   Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non-alcoholic steatohepatitis [J].
Alisi, A. ;
Bedogni, G. ;
Baviera, G. ;
Giorgio, V. ;
Porro, E. ;
Paris, C. ;
Giammaria, P. ;
Reali, L. ;
Anania, F. ;
Nobili, V. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (11) :1276-1285
[4]  
Ao N, 2015, HEPATOL RES, DOI [10.1111/hepr12551, DOI 10.1111/HEPR12551]
[5]  
Armstrong MJ, 2015, J HEPATOL, DOI [10.1016/jjhep201508038, DOI 10.1016/JJHEP201508038]
[6]  
Carbone LJ, 2015, J GASTROEN HEPATOL, DOI [10.1111/jgh13026, DOI 10.1111/JGH13026]
[7]   Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease [J].
Della Corte, Claudia ;
Liccardo, Daniela ;
Ferrari, Federica ;
Alisi, Anna ;
Nobili, Valerio .
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) :2501-2511
[8]   Liver Biopsy in Children: Position Paper of the ESPGHAN Hepatology Committee [J].
Dezsofi, Antal ;
Baumann, Ulrich ;
Dhawan, Anil ;
Durmaz, Ozlem ;
Fischler, Bjorn ;
Hadzic, Nedim ;
Hierro, Loreto ;
Lacaille, Florence ;
McLin, Valerie A. ;
Nobili, Valerio ;
Socha, Piotr ;
Vajro, Pietro ;
Knisely, Alexander S. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2015, 60 (03) :408-420
[9]   Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis [J].
Ferslew, Brian C. ;
Xie, Guoxiang ;
Johnston, Curtis K. ;
Su, Mingming ;
Stewart, Paul W. ;
Jia, Wei ;
Brouwer, Kim L. R. ;
Barritt, A. Sidney .
DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (11) :3318-3328
[10]   Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease [J].
Fitzpatrick, E. ;
Dew, T. K. ;
Quaglia, A. ;
Sherwood, R. A. ;
Mitry, R. R. ;
Dhawan, A. .
PEDIATRIC OBESITY, 2012, 7 (06) :471-479